vs
COHEN & STEERS, INC.（CNS）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是COHEN & STEERS, INC.的1.4倍（$197.9M vs $143.8M），COHEN & STEERS, INC.净利率更高（24.3% vs 6.7%，领先17.5%），REPLIGEN CORP同比增速更快（13.6% vs 2.9%），REPLIGEN CORP自由现金流更多（$17.6M vs $-126.4M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 8.3%）
科恩斯蒂尔是一家美国投资管理企业，专注于通过房地产投资信托（REIT）开展不动产证券投资，同时布局优先证券相关的另类收益类投资业务，在全球不动产和另类收益投资领域拥有专业的运营经验。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CNS vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$143.8M
营收增速更快
RGEN
高出10.8%
2.9%
净利率更高
CNS
高出17.5%
6.7%
自由现金流更多
RGEN
多$144.0M
$-126.4M
两年增速更快
RGEN
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $143.8M | $197.9M |
| 净利润 | $34.9M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 28.0% | 9.0% |
| 净利率 | 24.3% | 6.7% |
| 营收同比 | 2.9% | 13.6% |
| 净利润同比 | -23.9% | 143.9% |
| 每股收益（稀释后） | $0.67 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNSRGEN
| Q4 25 | $143.8M | $197.9M | ||
| Q3 25 | $141.7M | $188.8M | ||
| Q2 25 | $136.1M | $182.4M | ||
| Q1 25 | $134.5M | $169.2M | ||
| Q4 24 | $139.8M | $174.1M | ||
| Q3 24 | $133.2M | $154.9M | ||
| Q2 24 | $121.7M | $154.1M | ||
| Q1 24 | $122.7M | $151.3M |
净利润CNSRGEN
| Q4 25 | $34.9M | $13.3M | ||
| Q3 25 | $41.7M | $14.9M | ||
| Q2 25 | $36.8M | $14.9M | ||
| Q1 25 | $39.8M | $5.8M | ||
| Q4 24 | $45.8M | $-30.3M | ||
| Q3 24 | $39.7M | $-654.0K | ||
| Q2 24 | $31.8M | $3.3M | ||
| Q1 24 | $34.0M | $2.1M |
毛利率CNSRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率CNSRGEN
| Q4 25 | 28.0% | 9.0% | ||
| Q3 25 | 34.5% | 8.9% | ||
| Q2 25 | 31.8% | 7.6% | ||
| Q1 25 | 33.6% | 3.9% | ||
| Q4 24 | 35.3% | -17.7% | ||
| Q3 24 | 33.7% | -5.1% | ||
| Q2 24 | 31.5% | 1.0% | ||
| Q1 24 | 32.8% | 1.3% |
净利率CNSRGEN
| Q4 25 | 24.3% | 6.7% | ||
| Q3 25 | 29.4% | 7.9% | ||
| Q2 25 | 27.1% | 8.2% | ||
| Q1 25 | 29.6% | 3.4% | ||
| Q4 24 | 32.8% | -17.4% | ||
| Q3 24 | 29.8% | -0.4% | ||
| Q2 24 | 26.1% | 2.2% | ||
| Q1 24 | 27.7% | 1.4% |
每股收益（稀释后）CNSRGEN
| Q4 25 | $0.67 | $0.24 | ||
| Q3 25 | $0.81 | $0.26 | ||
| Q2 25 | $0.72 | $0.26 | ||
| Q1 25 | $0.77 | $0.10 | ||
| Q4 24 | $0.89 | $-0.55 | ||
| Q3 24 | $0.77 | $-0.01 | ||
| Q2 24 | $0.63 | $0.06 | ||
| Q1 24 | $0.68 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.5M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $562.0M | $2.1B |
| 总资产 | $876.7M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CNSRGEN
| Q4 25 | $145.5M | $767.6M | ||
| Q3 25 | $98.1M | $748.7M | ||
| Q2 25 | $95.4M | $708.9M | ||
| Q1 25 | $65.2M | $697.2M | ||
| Q4 24 | $183.0M | $757.4M | ||
| Q3 24 | $106.5M | $784.0M | ||
| Q2 24 | $122.0M | $809.1M | ||
| Q1 24 | $99.5M | $780.6M |
总债务CNSRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CNSRGEN
| Q4 25 | $562.0M | $2.1B | ||
| Q3 25 | $550.3M | $2.1B | ||
| Q2 25 | $528.5M | $2.1B | ||
| Q1 25 | $507.7M | $2.0B | ||
| Q4 24 | $511.7M | $2.0B | ||
| Q3 24 | $491.0M | $2.0B | ||
| Q2 24 | $463.2M | $2.0B | ||
| Q1 24 | $378.9M | $2.0B |
总资产CNSRGEN
| Q4 25 | $876.7M | $2.9B | ||
| Q3 25 | $801.6M | $2.9B | ||
| Q2 25 | $751.0M | $2.9B | ||
| Q1 25 | $834.9M | $2.9B | ||
| Q4 24 | $812.4M | $2.8B | ||
| Q3 24 | $727.8M | $2.8B | ||
| Q2 24 | $784.1M | $2.9B | ||
| Q1 24 | $680.7M | $2.8B |
负债/权益比CNSRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-120.4M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-126.4M | $17.6M |
| 自由现金流率自由现金流/营收 | -87.9% | 8.9% |
| 资本支出强度资本支出/营收 | 4.2% | 4.1% |
| 现金转化率经营现金流/净利润 | -3.45× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-253.6M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CNSRGEN
| Q4 25 | $-120.4M | $25.7M | ||
| Q3 25 | $55.1M | $48.1M | ||
| Q2 25 | $-67.6M | $28.6M | ||
| Q1 25 | $-108.9M | $15.0M | ||
| Q4 24 | $96.7M | $39.2M | ||
| Q3 24 | $25.6M | $49.3M | ||
| Q2 24 | $31.4M | $42.2M | ||
| Q1 24 | $4.9M | $44.7M |
自由现金流CNSRGEN
| Q4 25 | $-126.4M | $17.6M | ||
| Q3 25 | $52.6M | $43.4M | ||
| Q2 25 | $-69.8M | $21.5M | ||
| Q1 25 | $-110.0M | $11.4M | ||
| Q4 24 | $85.0M | $33.6M | ||
| Q3 24 | $24.2M | $42.3M | ||
| Q2 24 | $27.1M | $37.4M | ||
| Q1 24 | $537.0K | $36.4M |
自由现金流率CNSRGEN
| Q4 25 | -87.9% | 8.9% | ||
| Q3 25 | 37.1% | 23.0% | ||
| Q2 25 | -51.3% | 11.8% | ||
| Q1 25 | -81.8% | 6.8% | ||
| Q4 24 | 60.8% | 19.3% | ||
| Q3 24 | 18.2% | 27.3% | ||
| Q2 24 | 22.3% | 24.3% | ||
| Q1 24 | 0.4% | 24.0% |
资本支出强度CNSRGEN
| Q4 25 | 4.2% | 4.1% | ||
| Q3 25 | 1.8% | 2.5% | ||
| Q2 25 | 1.6% | 3.9% | ||
| Q1 25 | 0.8% | 2.1% | ||
| Q4 24 | 8.3% | 3.2% | ||
| Q3 24 | 1.1% | 4.5% | ||
| Q2 24 | 3.5% | 3.1% | ||
| Q1 24 | 3.5% | 5.5% |
现金转化率CNSRGEN
| Q4 25 | -3.45× | 1.93× | ||
| Q3 25 | 1.32× | 3.23× | ||
| Q2 25 | -1.84× | 1.92× | ||
| Q1 25 | -2.74× | 2.57× | ||
| Q4 24 | 2.11× | — | ||
| Q3 24 | 0.65× | — | ||
| Q2 24 | 0.99× | 12.70× | ||
| Q1 24 | 0.14× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
